Genome Toxicity and Impaired Stem Cell Function after Conditional Activation of CreER^T2 in the Intestine

Area of Science:

• Genetics
• Molecular Biology
• Stem Cell Biology

Background:

• The tamoxifen-inducible CreER^T2 system allows temporal control of genetic recombination in vivo.
• This technology is crucial for dissecting mammalian physiology and cell-type-specific functions.
• Its application in studying intestinal stem cells has potential confounding factors.

Purpose of the Study:

• To investigate the impact of CreER^T2 activation on intestinal stem cells.
• To identify potential drawbacks of using CreER^T2 technology in intestinal stem cell research.
• To analyze the effects of CreER^T2 on intestinal regeneration and stem cell function post-irradiation.

Main Methods:

• Utilized the intestine-specific Villin-CreER^T2 mouse strain.
• Administered tamoxifen to induce CreER^T2 activation.
• Assessed intestinal regeneration post-irradiation and analyzed DNA damage and loxP site cleavage.
• Evaluated the function of crypt base columnar stem cells and their organoid-initiating activity.

Main Results:

• Villin-CreER^T2 activation led to delayed intestinal regeneration after irradiation.
• CreER^T2 activation was associated with DNA damage and cryptic loxP site cleavage.
• Genome toxicity impaired the function of crypt base columnar stem cells, reducing organoid-initiating activity.
• Stem cell impairment was transient, with function returning to normal by 7 days post-tamoxifen treatment.

Conclusions:

• CreER^T2 technology can induce genome toxicity in intestinal stem cells.
• This toxicity can confound studies analyzing intestinal stem cell function and regeneration.
• Researchers using CreER^T2 in mouse models should consider these potential confounding effects on stem cell sensitivity to genotoxicity.